Login

If you are a member of the general public and not a healthcare professional, NOVELTY study investigator or AstraZeneca Medical employee, please CLICK HERE to see information tailored to you.

Study design

Home > Study design

Here you can find information on the design of NOVELTY and its sub-studies.

NOVELTY is a global, prospective, observational study, which is following ~12,000 patients over 3 years.

NOVELTY study animation

Watch our short animation to learn more about the NOVELTY study, who is eligible to take part and what we hope to achieve

NOVELTY study infographic

 

Download a PDF of the NOVELTY study infographic

 

Who are the patients?

Where are the patient data coming from?

What is being investigated?

Footnotes

*A phenotype is an observable characteristic or trait of a disease, such as morphology, development, biochemical or physiological properties, without necessarily any implication of a mechanism.
An endotype is a subtype of a condition, defined by a distinct functional or pathobiological mechanism.

 

19 PARTICIPATING COUNTRIESa
~12,000 ENROLLED PATIENTSa
80% OF PATIENTS HAVE SPIROMETRY DATAb

You are now leaving: http://aznoveltyproject.com/

By following this link you will be leaving the NOVELTY study website.

Please note that AstraZeneca does not take responsibility for the content displayed on other websites.

Continue Return to NOVELTY study